Медицинский совет, 2019 Today, chronic obstructive pulmonary disease is the fourth global cause of deaths worldwide. A number of studies showed that 11 to 16 million people might suffer from the chronic obstructive pulmonary disease in Russia.
Р. A. Balunov, A. N. Khitrov
doaj +1 more source
Tiotropium bromide, a long acting muscarinic receptor antagonist triggers intracellular calcium signalling in the heart [PDF]
, 2019 Background and purpose: Tiotropium bromide (TB) is a long acting muscarinic receptor antagonist used to manage chronic obstructive pulmonary disease (COPD). Recent meta-analyses suggest an increased risk of cardiovascular events with TB.
Cassambai, Shabana +3 more
core +1 more source
Therapeutics and Clinical Risk Management, 2016 Ching Kuo Tan, Gui Quan Say, James B Geake Department of Respiratory Medicine, Lyell McEwin Hospital, Elizabeth Vale, SA, Australia Abstract: Tiotropium bromide is a long-acting inhaled muscarinic antagonist used in patients with chronic respiratory ...
Tan CK, Say GQ, Geake JB
doaj
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. [PDF]
Int J Chron Obstruct Pulmon Dis, 2023 Requena G +12 more
europepmc +1 more source
Studies of Silver Bromide Clusters Isotopic Properties and Their Applications [PDF]
arXiv, 2019 The quantum size effect (QSE) studies of metallic and semiconductor nanoparticles have received considerable attention for their applications in superconductivity, visible light emission, quantum dot devices and industrial catalysts. The QSE properties of semiconductor AgBr nanoparticles have been thoroughly characterized for cluster larger than three ...
arxiv
Фармакоэкономика, 2016 The purpose of this study was to conduct the analysis of the structure and the rationality of cost in particular of providing preferential medicines patients with сhronic obstructive pulmonary disease (COPD) in Krasnoyarsk region.Materials and methods ...
T. V. Gaygolnik +5 more
doaj +1 more source
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol. [PDF]
J Manag Care Spec Pharm, 2023 Sethi S +7 more
europepmc +1 more source
Tiotropium bromide: additional options for the treatment of bronchial asthma
Russian Journal of Allergy, 2019 Bronchial asthma (BA) is one of the most common chronic diseases, characterized by airway inflammation and bronchospasm. Symptoms of BA are wheezing, shortness of breath, a feeling of constriction in the chest and cough, the frequency and severity of which vary greatly over time. Today studies of BA phenotypes allow selecting treatment depending on the
O M Kurbacheva, M E Dyneva
openaire +3 more sources
Клиническая практика, 2019 Objective. To study the effectiveness of carvedilol, tiotropium bromide and indacaterol in complex therapy on clinical and functional parameters in patients with CHF of ischemic origin in combination with COPD. Material and methods. The study included
Vladimir V. Evdokimov +2 more
doaj +1 more source
Tiotropium Bromide Attenuates Mucus Hypersecretion in Patients with Stable Chronic Obstructive Pulmonary Disease. [PDF]
Comput Math Methods Med, 2021 Yu S, Zhang C, Yan Z, Fang Q, Gao X.
europepmc +1 more source